Nature Reviews Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 60.7 | Q1 | 99.1% | 22.814 | Q1 | 100.0% |
| 2024 | 66.8 | Q1 | 99.4% | 24.378 | Q1 | 100.0% |
| 2023 | 72.5 | Q1 | 99.2% | 26.837 | Q1 | 100.0% |
| 2022 | 78.5 | Q1 | 99.2% | 20.977 | Q1 | 100.0% |
| 2021 | 69.8 | Q1 | 99.6% | 16.955 | Q1 | 99.9% |
| 2020 | — | — | 19.575 | Q1 | 99.9% | |
| 2019 | — | — | 21.287 | Q1 | 100.0% | |
| 2018 | — | — | 28.061 | Q1 | 100.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1474-1768
ISSN
1474-175X
region
Western Europe
coverage
2001-2026